Reply to bridges

Gene Therapy

Volumn 17, Issue 4, 2010, Pages 565-566

  Kaye, D M ^a   Byrne, M J ^a   Power, J M ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PARVOVIRUS VECTOR; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

BALLOON CATHETER; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; DRUG MEGADOSE; HEART ARREST; HEART CONTRACTION; HEART FAILURE; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INTRACORONARY INFUSION; LETTER; NONHUMAN; PRIORITY JOURNAL; SURGICAL APPROACH; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CORONARY CIRCULATION; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEART FAILURE; SHEEP;

EID: 77950859281     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2009.163     Document Type: Letter

References (5)

1. Bridges CR. 'Recirculating cardiac delivery' method of gene delivery should be called 'non-recirculating' method. Gene Therapy 2009; 16: 939-940.
2. Kaye DM, Preovolos A, Marshall T, Byrne M, Hoshijima M, Hajjar R et al. Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals. J Am Coll Cardiol 2007; 50: 253-260.
3. Byrne MJ, Power JM, Preovolos A, Mariani JA, Hajjar RJ, Kaye DM. Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals. Gene Therapy 2008; 15: 1550-1557.
4. Davidson MJ, Jones JM, Emani SM, Wilson KH, Jaggers J, Koch WJ et al. Cardiac gene delivery with cardiopulmonary bypass. Circulation 2001; 104: 131-133.
5. Penny DJ, Smolich JJ. Divergent effects of NO synthase inhibition on systemic and myocardial O2 delivery and consumption during dobutamine infusion in sheep. Pflugers Arch 2002; 443: 601-608.